CoChat

Challenges and opportunities for the next generation of cardiovascular tissue engineering

Open access
Cho, Sangkyun, Discher, Dennis E., Leong, Kam W., Vunjak-Novakovic, Gordana, Wu, Joseph C. · 2022 · Nature Methods

The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.

Abstract

Engineered cardiac tissues derived from human induced pluripotent stem cells offer unique opportunities for patient-specific disease modeling, drug discovery and cardiac repair. Since the first engineered hearts were introduced over two decades ago, human induced pluripotent stem cell-based three-dimensional cardiac organoids and heart-on-a-chip systems have now become mainstays in basic cardiovascular research as valuable platforms for investigating fundamental human pathophysiology and development. However, major obstacles remain to be addressed before the field can truly advance toward commercial and clinical translation. Here we provide a snapshot of the state-of-the-art methods in cardiac tissue engineering, with a focus on in vitro models of the human heart. Looking ahead, we discuss major challenges and opportunities in the field and suggest strategies for enabling broad acceptance of engineered cardiac tissues as models of cardiac pathophysiology and testbeds for the development of therapies. In this Perspective, technologies and challenges in the cardiac tissue engineering field are discussed and strategies to overcome these challenges are proposed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41592-022-01591-3

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 86 references

Cited by

See all 176

Metadata

Authors
Cho, S., Discher, D. E., Leong, K. W., Vunjak-Novakovic, G., & Wu, J. C.
Affiliations
  • Stanford Medicine (US)
  • University of Pennsylvania (US)
  • Columbia University (US)
Corresponding author
Wu, Joseph C.
Venue
Nature Methods
Published
2022-09
Volume
19
Issue
9
Pages
1064-1071
ISSN
  • 1548-7091 (ISSN-L)
  • 1548-7105
OpenAlex
W4294636458
Cited by
176
References
86
Citations by year
2026: 37 · 2025: 50 · 2024: 53 · 2023: 32 · 2022: 4
FWCI
3.61
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Methods (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
U.S. Department of Health & Human Services | National Institutes of Health (R01 HL126527, R01 HL130020, R01 HL146690, R01 HL150693, UH3 TR002588, F32 HL152483)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
Keywords
cardiovascular tissue engineering, human induced pluripotent stem cells, cardiac organoids, heart-on-a-chip, engineered heart tissue, patient-specific disease modeling, cardiac repair, drug discovery, clinical translation, cardiac pathophysiology
MeSH terms
Heart, Humans, Organoids, Tissue Engineering, Myocytes, Cardiac, Drug Discovery, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Challenges and opportunities for the next generation of cardiovascular tissue engineering. https://app.cochat.ai/papers/10.1038/s41592-022-01591-3
The paper
Cho, S., Discher, D. E., Leong, K. W., Vunjak-Novakovic, G., & Wu, J. C. (2022). Challenges and opportunities for the next generation of cardiovascular tissue engineering. Nature Methods. https://doi.org/10.1038/s41592-022-01591-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.